Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative GroupKatie M. O’Brien, Dale P. Sandler, William J. Blot et al.|The Lancet Oncology|2025Cited by 12
Plasma prolactin and postmenopausal breast cancer risk: a pooled analysis of four prospective cohort studiesJacob K. Kresovich, Susan E. Hankinson, Catherine Guranich et al.|Breast Cancer Research|2024Cited by 4
Central and peripheral adiposity and premenopausal breast cancer risk: a pooled analysis of 440,179 womenMinouk J. Schoemaker, Taylor D. Ellington, Hazel B. Nichols et al.|Breast Cancer Research|2025Cited by 4
Development and validation of a risk prediction model for premenopausal breast cancer in 19 cohortsKristen D. Brantley, A. Heather Eliassen, Michael E. Jones et al.|Breast Cancer Research|2025Cited by 2